Skip to main navigation Skip to search Skip to main content

Integrin B3 inhibition enhances the antitumor activity of ALK inhibitor in ALK-rearranged NSCLC

  • Sungkyunkwan University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Integrin B3 inhibition enhances the antitumor activity of ALK inhibitor in ALK-rearranged NSCLC'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology